Quality of TB Care


Poor quality TB care is widespread and is a key driver of the TB epidemic. This course will address the critical need to go beyond coverage and improve quality of TB care in low and middle-income countries.


Course Directors

Madhukar Pai, MD, PhD
Professor of Epidemiology, McGill University
Director, McGill Global Health Programs
Director, McGill International TB Centre


Zelalem Temesgen, MD
Director, Mayo Clinic Center for Tuberculosis


Jishnu Das, PhD
Professor, McCourt School of Public Policy and School of Foreign Service, Georgetown University

Course Faculty

Bruce Agins, MD – UCSF & HealthQual

Adithya Cattamanchi, MD – UCSF

Carmen Christian – University of Western Cape

Amrita Daftary, PhD, MPH – York University

Benjamin Daniels, Georgetown University

Margaret Kruk, MD – Harvard T.H. Chan School of Public Health

Ada Kwan, MHS – University of California, Berkley

Elysia Larson – Harvard T.H. Chan School of Public Health

Lindiwe Mvusi – National Department of Health, South Africa

Ramnath Subbaraman, MD – Tufts University School of Medicine

Nandita Venkatesan – Survivors Against TB, India


Faculty are still being confirmed and there may be changes to the above list.



In order to end TB, we need to increase access to TB care and simultaneously ensure that the care provided is of sufficiently high quality (i.e. care that is safe, effective, patient-centered,
timely, efficient, and equitable). There is plenty of evidence that quality of TB (and TB-HIV coinfection and MDR-TB) care is poor in many settings, and this is a key reason for the high mortality rate seen in LMICs. This means National TB programs need to think beyond coverage of TB services; they need to start measuring and systematically improving quality of TB care in LMICs. This session of leading international experts will:
• Discuss and debate the best approaches to measurement of quality of TB care
• Review data on quality of TB care and factors that drive variation in care
• Explore quality of TB care in private versus public sectors
• Give examples of quality improvement programs in TB as well as other areas of global health (e.g. from HIV/AIDS) that have worked or failed through case study lessons
• Explain the use of quality dashboards, audits and tools, and their likely impact on quality
• Give strategies for understanding and overcoming the pervasive know-do gap, including training, mentoring, incentives, and system-wide changes for high-quality health systems



By the end of the course, participants will be able to:

  • Review various approaches to measuring quality of TB care in low-resource settings
  • Summarize current evidence on quality of TB care, and give examples of quality improvement programs that have worked or failed
  • Describe the role of research in understanding variation in quality, the know-do gap, and provider performance improvement


Target Audience

  • National TB Program managers and program implementers
  • Clinicians and nurses
  • Researchers and academics involved in TB care and prevention
  • Funding agencies
  • Product development partnerships
  • Policy makers and public health implementers
  • Community advocates and civil society



Maximum of 100 participants.